neferine has been researched along with d-alpha tocopherol in 1 studies
| Studies (neferine) | Trials (neferine) | Recent Studies (post-2010) (neferine) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
|---|---|---|---|---|---|
| 165 | 0 | 120 | 32,198 | 2,903 | 7,258 |
| Protein | Taxonomy | neferine (IC50) | d-alpha tocopherol (IC50) |
|---|---|---|---|
| Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Li, G; Liang, S; Liu, S; Peng, H; Tu, G; Xiao, W; Xu, H; Zheng, C; Zhu, G | 1 |
1 other study(ies) available for neferine and d-alpha tocopherol
| Article | Year |
|---|---|
Neferine inhibits the upregulation of CCL5 and CCR5 in vascular endothelial cells during chronic high glucose treatment.
Topics: Antioxidants; Benzylisoquinolines; Cell Survival; Cells, Cultured; Chemokine CCL5; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Nitric Oxide; Oxidoreductases; Reactive Oxygen Species; Receptors, CCR5; Up-Regulation; Vitamin E | 2013 |